U.S. RESEARCH ROUNDUP-Incyte, ServiceNow, Spire Global

+4.74%

+2.53%

+0.38%

+0.60%

-0.50%

Spire Global, Inc. Class A SPIR	9.38	+4.74%
VSE Corporation VSEC	222.07	+2.53%
ServiceNow, Inc. NOW	113.62	+0.38%
Vertex Pharmaceuticals Incorporated VRTX	477.12	+0.60%
Incyte Corporation INCY	97.58	-0.50%

Dec 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Incyte, ServiceNow and Spire Global, on Wednesday.

HIGHLIGHTS

* Incyte INCY.O: Truist Securities raises target price to $103 from $93

* ServiceNow NOW.N: TD Cowen adjusts PT to $250 from $1,250 to reflect 5-for-1 stock split

* Spire Global Inc SPIR.N: Alliance Global Partners cuts to neutral from buy

Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.

* Huron Consulting Group Inc HURN.O: Benchmark raises target price to $215 from $180

* Incyte INCY.O: Truist Securities raises target price to $103 from $93

* ServiceNow NOW.N: TD Cowen adjusts PT to $250 from $1,250 to reflect 5-for-1 stock split

* Spire Global Inc SPIR.N: Alliance Global Partners cuts to neutral from buy

* Spire Global Inc SPIR.N: Alliance Global Partners cuts target price to $9 from $17

* Vertex Pharmaceuticals Inc VRTX.O: Leerink Partners raises PT to $525 from $456

* Vse Corp VSEC.O: Jefferies raises target price to $215 from $210

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.